Curatio is thrilled to announce our CEO and Founder, Lynda Brown-Ganzert, has been selected as Trailblazer Vanguard Award finalist. Although decades of research has shown the positive impact social support can have on everything from health outcomes to adherence to behavioural change, there has never been a way to prescribe this support at scale. Lynda made it her mission to change this, and introduced the notion of a social health prescription to the healthcare industry at a time when scalable, personalized, technology enabled patient support is desperately needed. The need to reduce loneliness and isolation, the need to provide personalized, daily adherence and compliance support, the need to ensure no patient is alone on their health journey is Curatio’s contribution to the Vanguard category.
Please see full release below.
Vancouver, BC, August 11, 2021 – PM360, a publication for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries, recently named Lynda Brown-Ganzert as a Trailblazer Vanguard Award finalist.
Curatio is the world’s first social health prescription. When Curatio Founder and CEO, Lynda Brown-Ganzert became a patient, she recognized that her challenges were shared by millions of others and represented a massive need in the industry. Wanting to help others avoid the isolation, stigma, lack of evidence-based information and the navigation difficulties that come with any diagnosis, she turned to technology to deliver social support at scale. Now used in 104 countries, available in 20 languages, Curatio’s mission of No Patient Alone is standardizing the integration of social support as a critical component of effective disease management.
Since 2009, the PM360 Trailblazer awards have recognized outstanding achievement and innovation in healthcare marketing. Each year, nominations are judged by the PM360 Editorial Advisory Board, a distinguished cross-section of industry experts. The Vanguard Award, which was just added last year, honors an industry pioneer who developed a new service, strategy, product, or technology that greatly impacted the industry.
“The accomplishments of this year’s finalists are already deeply ingrained in our industry,” says Anna Stashower, CEO and Publisher of PM360. “Thanks to their work our industry now has a physician-only programmatic marketing platform, a patient-support program that is driving improved adherence rates, a social health prescription that guides patients to personalized help for them, and a new way to utilize modern MarTech while enabling marketing sophistication. These leaders are proving that one good idea and a whole lot of work can transform lives”
Finalists are acknowledged and winners will be announced during a special virtual celebration on Thursday, September 23, at 6 pm EST. Tickets for the virtual Trailblazer Awards Event can be purchased by visiting www.pm360online.com/trailblazer-tickets. Profiles of all of the winners will be included in PM360’s October issue.
For more information about the awards or tickets, contact Kayla Walsh at 646-300-8117 or firstname.lastname@example.org.
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.
The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: Planning and implementation of cutting edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the “360” in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read.
By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.
Curatio enables payers, providers, researchers and pharmaceutical manufacturers to compliantly engage with patients on their own social networks. Curatio provides a private, secure social network platform that uses proprietary algorithms, AI and machine learning to match patients to the peer support, programs and daily management tools that help them live their healthiest lives. Used in 102 countries, available in 20+ languages, Curatio has won numerous awards for its unique technical solution and its mission of No Patient Alone.